Fast-tracking development and regulatory approval of COVID-19 vaccines in the EU: A review of ethical implications

The rapid spread of SARS-CoV-2 worldwide has triggered intense activity in the field of biotechnology, leading to the development and regulatory approval of multiple COVID-19 vaccines in less than 1 year while raising sustained scrutiny as to the ethical issues associated with this process. This art...

Full description

Saved in:  
Bibliographic Details
Authors: Beretta, Giorgia (Author) ; Marelli, Luca (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Wiley-Blackwell 2023
In: Bioethics
Year: 2023, Volume: 37, Issue: 5, Pages: 498-507
IxTheo Classification:NCH Medical ethics
TK Recent history
Further subjects:B COVID-19 vaccines
B fast-tracking
B R&D
B regulatory process
B ethical issues
B marketing authorization
Online Access: Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002 4500
001 1845791339
003 DE-627
005 20230523175704.0
007 cr uuu---uuuuu
008 230520s2023 xx |||||o 00| ||eng c
024 7 |a 10.1111/bioe.13151  |2 doi 
035 |a (DE-627)1845791339 
035 |a (DE-599)KXP1845791339 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Beretta, Giorgia  |e VerfasserIn  |4 aut 
245 1 0 |a Fast-tracking development and regulatory approval of COVID-19 vaccines in the EU: A review of ethical implications 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a The rapid spread of SARS-CoV-2 worldwide has triggered intense activity in the field of biotechnology, leading to the development and regulatory approval of multiple COVID-19 vaccines in less than 1 year while raising sustained scrutiny as to the ethical issues associated with this process. This article pursues a twofold objective. First, it reconstructs and provides a thorough overview of the different steps, from clinical trial design to regulatory procedures, underpinning the “fast-tracking” of COVID-19 vaccine R&D and approval. Second, drawing on a review of published literature, the article identifies, outlines, and analyzes the most ethically challenging aspects related to such process, including concerns around vaccine safety, issues in study design, the enrollment of study participants, and the challenges in obtaining valid informed consent. By scrutinizing relevant aspects of COVID-19 vaccine development and regulatory processes leading to market authorization, this article ultimately aims to provide a comprehensive overview of the regulatory and ethical issues underpinning the roll-out of this key pandemic-containment technology worldwide. 
601 |a COVID-19 
650 4 |a regulatory process 
650 4 |a marketing authorization 
650 4 |a fast-tracking 
650 4 |a ethical issues 
650 4 |a R&D 
650 4 |a COVID-19 vaccines 
652 |a NCH:TK 
700 1 |a Marelli, Luca  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Bioethics  |d Oxford [u.a.] : Wiley-Blackwell, 1987  |g 37(2023), 5, Seite 498-507  |h Online-Ressource  |w (DE-627)271596708  |w (DE-600)1480658-7  |w (DE-576)078707986  |x 1467-8519  |7 nnns 
773 1 8 |g volume:37  |g year:2023  |g number:5  |g pages:498-507 
856 |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bioe.13151  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via crossref license)] 
856 4 0 |u https://doi.org/10.1111/bioe.13151  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.13151  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
936 u w |d 37  |j 2023  |e 5  |h 498-507 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4323963246 
LOK |0 003 DE-627 
LOK |0 004 1845791339 
LOK |0 005 20230523175704 
LOK |0 008 230520||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2023-05-19#1BE70EC30703C0950A70A74136945B7E91D7C8AE 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a zota 
LOK |0 936ln  |0 1442053887  |a TK 
LOK |0 936ln  |0 1550736558  |a NCH 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw 
REL |a 1 
SUB |a REL